Kenneth Dootson, of Marlborough, died prematurely at age 75 because of Yale's misdiagnosis of cancer that had spread to his ...

Real-world data supports Opdivo plus Yervoy efficacy for advanced renal cell carcinoma, mirroring clinical trial results.

Advancements in targeted therapies have transformed the treatment landscape for NSCLC, enabling precision medicine approaches that improve outcomes. These therapies focus on specific genetic mutations ...

An elderly Englishman got diagnosed with prostate cancer after he went to a dentist to get his recurrent toothache treated. According to experts, despite the doctor extracting his tooth, he continued ...

Those who regularly wear saris and petticoats that are tied around the waist tightly for a long time are prone to skin ...

Hoag physicians testing promising options for the diagnosis and treatment of glioblastoma (GBM), the deadliest form of brain cancer The LIBERATE study (NCT05383872), sponsored by INSIGHTEC, evaluates ...

While low-to-moderate alcohol use isn't always harmful, heavy drinking can trigger inflammation and worsen symptoms of ...

Repare Therapeutics (RPTX) announced a re-alignment of resources and a re-prioritization of its clinical portfolio to focus on the continued ...

9, 2025 — Researchers have shown that a test called ORACLE can predict lung cancer survival at the point ... algorithm to predict accurately brain metastasis using biopsy samples from early ...

Repare Therapeutics Inc. ("Repare" or the "Company") (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced a re-alignment of resources and a re-prio ...

Some other medicines that are slated to become blockbusters in the near future include GSK’s vaccine candidate GSK-3536819 ...

The combination of brain radiotherapy and chemoimmunotherapy “resulted in promising intracranial and systemic anti-tumor activity, with a manageable safety profile,” researchers wrote.